Since September 7th, there has been temporary supply of AUVI-Q® epinephrine auto-injectors available across pharmacies in Canada. This additional stock is meant to help mitigate the current ongoing supply constraints of the EpiPen® 0.3 mg dose. AUVI-Q auto-injectors were previously known as Allerject auto-injectors in Canada. Read our FAQs on the AUVI-Q temporary supply.
We want your input on the status of these supply constraints. Your information is vital in directing our advocacy efforts. Please take our 5-minute survey to share your experiences. Your information will be kept confidential and will only be used to help inform us.
We will continue advocating hard on increasing accessibility to epinephrine in Canada. With the temporary supply in place for the short-term, we want to make sure you are getting access to available supply. At the same time, we continue to focus on the longer-term goal of ensuring there are at least two epinephrine auto-injector suppliers in Canada.
You have our commitment that we will continue our ongoing collaborations with the Government of Canada, the Provinces, pharmaceutical companies, and other key stakeholders until there is a resolution to this issue…
Lesen Sie weiter auf: We need your input: Access to EpiPen and AUVI-Q epinephrine auto-injectors
Quelle: Food Allergy Canada
Titelbild/Grafik by Food Allergy Canada
Kommentare und Fragen
Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!Weiteres von Food Allergy Canada
